Trace blood on urinalysis in pregnancy
Trace blood on urine dipstick should not be assumed to represent true hematuria. Microscopic urinalysis is recommended to confirm red blood cells (RBCs) because dipstick “blood” can be caused by non-hematuria sources. [1]
Confirmation of true hematuria
- Microhematuria should be defined by microscopic evaluation as ≥3 RBCs per high-power field on a single, properly collected urine specimen. [2]
- If a urinary tract infection (UTI) is suspected and treated, repeat urinalysis with microscopic evaluation after treatment is recommended to document hematuria resolution. [2]
- Contamination from vaginal bleeding should be considered when trace blood is detected. [1]
Initial assessment to guide management
Pregnancy-specific assessment should prioritize benign and treatable causes before considering structural or nephrologic etiologies. [1],[2]
Recommended components of evaluation include:
- History for urinary symptoms (dysuria, frequency, urgency), flank pain, fever, gross hematuria, and timing relative to menstruation/vaginal bleeding. [1],[4]
- Physical examination including blood pressure measurement. [2]
- Urine culture when UTI is suspected based on symptoms and urinalysis findings. [4]
- Serum creatinine and assessment for proteinuria or other indicators of renal parenchymal disease when microscopic hematuria is confirmed. [2]
Management when infection is present
UTI should be evaluated and treated promptly when consistent with clinical presentation and urinalysis results. [4]
- UTI suspicion in pregnancy is supported by urinalysis findings and symptoms, and confirmation is based on urine culture demonstrating ≥100,000 CFU/mL. [4]
- Empiric treatment may be initiated for symptomatic patients when urinalysis is consistent with UTI. [4]
- Hematuria resolution should be confirmed with repeat microscopic urinalysis after antimicrobial treatment. [2]
Management when infection is not present
When microscopic hematuria is confirmed and infection is not identified or does not explain the finding, evaluation should follow general microhematuria frameworks while minimizing fetal risks from imaging. [1],[2],[5]
Structural and benign causes should be prioritized over malignancy in pregnancy. [1],[5]
Imaging approach in pregnancy
Ionizing-radiation imaging for microhematuria should generally be avoided when lower-risk alternatives can answer the clinical question. [5]
- Renal and bladder ultrasound is recommended as the initial imaging modality for pregnant patients with microhematuria. [5]
- For screening major renal lesions in pregnancy, the AUA approach described in a clinical summary recommends magnetic resonance (MR) urography or retrograde pyelography in combination with renal ultrasound. [3]
- Intravenous urography is not used as a first-line imaging modality for microhematuria in pregnancy. [5]
When to escalate care
Escalation should be based on the presence of clinically significant hematuria or concern for complicated disease. [2]
- Gross hematuria warrants further evaluation beyond pregnancy-focused reassessment for benign causes. [2]
- Referral to urology and/or nephrology should be considered when microscopic hematuria is confirmed with features suggesting medical renal disease (such as proteinuria, dysmorphic RBCs, RBC casts, or impaired renal function). [2]
Monitoring and follow-up
- Hematuria should be reassessed after treatment of a suspected UTI to confirm resolution. [2]
- Persistent confirmed microscopic hematuria after exclusion of benign causes warrants completion of the pregnancy-appropriate microhematuria evaluation pathway. [2],[5]